Akos Biosciences

Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023. Q1 2023 Financial Highlights Net loss attributable to shareholders was $4.80 million for the quarter ended March 31, 2023, including $0.56...